US20120116214A1 - Multimodal Catheter System and Method for Intravascular Analysis - Google Patents
Multimodal Catheter System and Method for Intravascular Analysis Download PDFInfo
- Publication number
- US20120116214A1 US20120116214A1 US13/290,438 US201113290438A US2012116214A1 US 20120116214 A1 US20120116214 A1 US 20120116214A1 US 201113290438 A US201113290438 A US 201113290438A US 2012116214 A1 US2012116214 A1 US 2012116214A1
- Authority
- US
- United States
- Prior art keywords
- optical
- fiber
- optical fiber
- arterial wall
- catheter system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004458 analytical method Methods 0.000 title abstract description 44
- 238000000034 method Methods 0.000 title abstract description 21
- 238000001514 detection method Methods 0.000 claims abstract description 8
- 230000003287 optical effect Effects 0.000 claims description 57
- 239000000835 fiber Substances 0.000 claims description 36
- 238000002604 ultrasonography Methods 0.000 claims description 34
- 244000208734 Pisonia aculeata Species 0.000 claims description 25
- 239000013307 optical fiber Substances 0.000 claims description 23
- 230000005855 radiation Effects 0.000 claims description 14
- 238000003384 imaging method Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 4
- 238000002608 intravascular ultrasound Methods 0.000 abstract description 52
- 238000012014 optical coherence tomography Methods 0.000 abstract description 48
- 238000004497 NIR spectroscopy Methods 0.000 abstract description 2
- 230000005856 abnormality Effects 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 13
- 238000001069 Raman spectroscopy Methods 0.000 description 11
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000000126 substance Substances 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 230000004044 response Effects 0.000 description 7
- 230000003595 spectral effect Effects 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000002583 angiography Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000001338 necrotic effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000004611 spectroscopical analysis Methods 0.000 description 4
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000003143 atherosclerotic effect Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 230000003176 fibrotic effect Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 3
- 238000007634 remodeling Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000010183 spectrum analysis Methods 0.000 description 3
- 208000037804 stenosis Diseases 0.000 description 3
- 230000036262 stenosis Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000012921 fluorescence analysis Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 230000002885 thrombogenetic effect Effects 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229910000530 Gallium indium arsenide Inorganic materials 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006497 arterial abnormality Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002586 coronary angiography Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4444—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
- A61B8/4461—Features of the scanning mechanism, e.g. for moving the transducer within the housing of the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
- A61B5/0035—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0066—Optical coherence imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
- A61B5/0086—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters using infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0093—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy
- A61B5/0095—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy by applying light and detecting acoustic waves, i.e. photoacoustic measurements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4416—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to combined acquisition of different diagnostic modalities, e.g. combination of ultrasound and X-ray acquisitions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
Definitions
- Atherosclerosis is a vascular disease characterized by the modification of the walls of blood carrying vessels. This modification can take the form of thickening of the vessel wall, eventually forming what are commonly referred to as “plaques.”
- plaques The mechanisms corresponding to the formation, progression, stabilization, or rupture of these plaques and their effects on humans has been an area of intense research in intravascular medicine.
- interventional cardiology and percutaneous diagnostic and treatment procedures the patient with coronary atherosclerotic disease was no longer required to automatically submit to coronary by-pass surgery—an extremely invasive procedure with attendant risks and extended recovery time.
- Coronary stents were developed to revascularize narrowed (stenosed) vessels and millions of theses devices have been placed in patients worldwide.
- current statistics show that, while patient comfort and quality of life has been improved, treatment of coronary atherosclerotic disease by stenting has not significantly reduced the patient mortality. Patients treated with stents are still dying suddenly of heart attack.
- plaques seem to have formed a reservoir, or core, of thrombogenic material behind a layer of fibrous tissue (“cap”), analogous to an abscess.
- cap fibrous tissue
- the integrity of the fibrous layer can become compromised, whereby blood can eventually come into contact with the thrombogenic core. This can be a sudden event, where the patient had no prior warning or even symptoms. If one categorizes plaques broadly as stable—where they may still progress slowly and eventually restrict the vessel—and unstable—those that can change their status rapidly, among the key questions is: “How can we tell the difference?”
- Angiography is one of the oldest intravascular technologies employed for this purpose.
- the technique typically employs a catheter, introduced percutaneously into the vasculature, that is used to inject a contrast agent, consisting of a radio opaque dye, into the blood vessels of interest.
- a contrast agent consisting of a radio opaque dye
- x-rays a two dimensional live (cine) or still image of the vasculature can be obtained.
- the vessel lumen is visible wherever the contrast agent is able to flow. From these images, one can determine the size of the lumen and the presence of any narrowing or blockage. The presence of a plaque can sometimes be inferred by a diffuse lumen boundary.
- vessel narrowing is not necessarily rotationally isotropic. With only a single view angle from which to form the 2-D image, areas of narrowing can be underestimated or missed entirely.
- To obtain images from multiple viewpoints requires more time and exposure of the patient to contrast and x-rays.
- the nature of the image as a “lumenogram,” along with limited spatial resolution, make it difficult, if not impossible, to make any statement about the characteristics of the tissue in the vessel wall. For example, it is impossible to distinguish between a fibrotic plaque and one with a necrotic, lipid filled core.
- IVUS Intravascular ultrasound
- mechanical IVUS catheters consist of a flexible polymer outer sheath, inside of which is a core that rotates and pulls back through the vessel, generating a series of circumferential scans of the vessel wall.
- the core typically consists of an RF transmission line, connecting the transducer at the distal tip to drive and receive electronics.
- a helically wound wire cable is typically used to transmit torque from a rotary motor, through the core to the distal tip, to ensure rotation of the tip with consistent angular velocity.
- Ultrasonic waves are back scattered by human tissue.
- the strength of the back scatter is a function of tissue properties, including density.
- the signal returning from tissue from a rotating IVUS catheter can be represented as a radar plot with a 360 degree view of a section of the vessel and the radial dimension showing the strength of the signal return as a function of distance from the center of the catheter.
- OCT optical coherence tomography
- IVUS Optical coherence tomography
- OCT depends on the scattering of light by tissue and uses the coherence properties of light, for example, using a Michelson interferometer, to determine the distance at which a scattering event occurred.
- the technique is similar to IVUS in that a catheter is moved over a guidewire into the blood vessel to a region of interest and then the core of the catheter is pulled back to scan the artery.
- the OCT signal cannot penetrate blood, requiring that the blood be cleared from the area of the vessel being imaged.
- NIR near infrared
- Raman Raman
- fluorescence spectral analysis Another class of intravascular analysis systems uses chemical analysis modalities. These approaches generally rely on optical spectral analysis including near infrared (NIR), Raman, and fluorescence spectral analysis.
- NIR Near Infrared Spectroscopy
- NIRS utilizes an intravascular optical catheter which, similarly to IVUS, is driven by a pullback and rotation unit that simultaneously rotates the catheter head around its longitudinal axis while withdrawing the catheter head through the region of the blood vessel of interest.
- the spectral response of the inner vessel walls is acquired in a raster scan operation.
- This provides a spatially-resolved spectroscopic analysis of the region of interest.
- the strategy is that by determining the spectroscopic response of blood vessel walls, the chemical constituents of those blood vessel walls can be determined by application of chemometric analysis, for example.
- the inner walls of the blood vessel are illuminated by a narrow band, such as laser, signal.
- the Raman spectral response is then detected. This response is generated by the inelastic collisions betweens photons and the chemical constituents in the blood vessel walls. This similarly produces chemical information for the vessel walls.
- Hybrid IVUS/optical catheters have been proposed.
- a “device for vulnerable plaque detection” is disclosed.
- this patent is directed to intravascular probe that includes optical waveguides and ports for the near infrared analysis of the blood vessel walls while simultaneously including an ultrasound transducer in the probe in order to enable IVUS analysis of the blood vessel walls.
- aspects of the invention relate to systems, methods, and apparatus for combining three or more intravascular analysis modalities—and thereby exploiting the different diagnostic information available from each modality—in a single intravascular procedure.
- a single catheter combines multiple diagnostic modalities, such as 3, 4 or even 5 diagnostic modalities.
- diagnostic modalities such as 3, 4 or even 5 diagnostic modalities.
- two or more of the diagnostic modalities are used simultaneously, even during the same pullback and rotation cycle.
- the modalities are employed serially in separate pullback and rotation cycles.
- lumen dimension stenosis
- vessel dimension positive remodeling
- cap thickness a possible indicator of plaque vulnerability
- a catheter that combines NIR, IVUS, OCT and a flow wire provides the physician with a much more comprehensive data set from which to formulate a therapy decision, including stenting, medical therapy, or referral to coronary artery bypass grafting (CABG).
- CABG coronary artery bypass grafting
- a further consideration is the “fusing” of image data obtained from different modalities (e.g. angiography, NIR, OCT, IVUS) and the accurate spatial co-registration (longitudinal and rotational) of the images.
- modalities e.g. angiography, NIR, OCT, IVUS
- the accurate spatial co-registration longitudinal and rotational
- Having one catheter that incorporates multiple invasive imaging modalities provides a fixed frame of reference that greatly facilitates co-registration, especially when the diagnostic modalities are employed during the same pullback and rotation cycle.
- Success here is further facilitated by including position detection capabilities in the catheter such as sensors that detect externally-generated signals, magnetic fields, or emitters that generate externally detected signals.
- FIG. 1 is a cross-sectional view of an intravascular probe with a guidewire in a distal end of a catheter;
- FIG. 2 is a schematic diagram illustrating the use of the catheter system and a system controller, according to the invention.
- FIGS. 3-7 are schematic diagrams illustrating embodiments 1-5 having different component layouts between the pullback and rotation unit 105 and a console 106 .
- IVUS analysis provides valuable information regarding certain structural aspects of an arterial wall that enables the practitioner to identify gross structural abnormalities, such as stenosis and other forms of remodeling
- IVUS suffers from a number of inherent limitations relevant to the objective of characterizing plaque composition. For this reason, efforts to extend the capability of IVUS to actual characterization of tissue type (e.g. calcific, fibrotic, necrotic) in an effort to differentiate types of plaques and better inform treatment have been largely unsuccessful.
- tissue type e.g. calcific, fibrotic, necrotic
- calcified regions block the propagation of IVUS radiation. It is not uncommon for a coronary plaque to be covered with a calcific cap, and therefore, such plaque may go undetected in an IVUS analysis.
- softer plaques, which often contain lipids are generally hypoechoic. Thus, it is from an absence of signal that one must infer the plaque composition.
- Use of a null signal to infer plaque properties is not ideal and can be subject to errors.
- OCT like IVUS, provides information regarding the structural aspects of the arterial wall but has the capability to generate images with up to ten times better resolution than IVUS. This now enables the visualization of structures which cannot be seen with IVUS. In particular, the thickness of the fibrous cap covering a plaque with a necrotic core can now be measured with high precision.
- OCT optical signals are severely attenuated by blood and also have limited penetration in tissue. Not only does this mean that it is necessary to clear blood from the vessel, as mentioned previously, but the imaging depth in tissue achievable with OCT is limited to approximately 1 mm.
- NIRS as described above, provides information regarding the chemical constitution of the artery to identify the, cholesterol, or lipids content of the artery.
- the inventors have determined that the combination of at least these three diagnostic modalities can significantly enhance the efficacy of the intraluminal analysis. For example, by identifying a variety of arterial abnormalities, such as positive remodeling (best detectable by IVUS), thin caps (best detectable by OCT), and a necrotic core (best detectable by spectroscopy, e.g., NIR), the diagnostic accuracy can be significantly improved. Moreover, by combining at least these three modalities in a single system, apparatus, and method, these multiple informational components used in the diagnosis can be obtained in a single intravascular procedure.
- FIG. 1 shows an embodiment of an intravascular catheter system 100 that combines multiple diagnostic modalities.
- the intravascular catheter 100 is advanced into a blood vessel 18 using a guidewire 108 that is threaded through the guidewire lumen 110 .
- the catheter system 100 further comprises an inner scanning catheter core 116 and outer sheath 114 .
- the combination of the scanning catheter core 116 and sheath 114 enables the inner scanning catheter core 116 and specifically the catheter tip 112 to perform longitudinal translation (arrow 50 ) and rotation (arrow 52 ) while the sheath 114 prevents this movement from damaging the vessel 18 and specifically walls 104 .
- the tip 112 of the scanning catheter core 116 is located at the distal end of the catheter 100 and includes an optical bench 118 to transmit and receive light, typically infrared light, and an ultrasound transducer system 120 to transmit and receive ultrasound energy.
- an optical bench 118 to transmit and receive light, typically infrared light
- an ultrasound transducer system 120 to transmit and receive ultrasound energy.
- At least the distal end of the sheath 114 is composed of materials that are transparent to light, e.g., near infrared, employed by the optical diagnostic modalities (e.g., a polymer) and will also propagate ultrasound used by IVUS.
- materials that are transparent to light e.g., near infrared, employed by the optical diagnostic modalities (e.g., a polymer) and will also propagate ultrasound used by IVUS.
- the optical bench 118 contains the terminations 122 t, 123 t of at least one delivery fiber 122 and at least one collection fiber 123 , which extend between the proximal and distal ends of the catheter 100 .
- Light 125 propagating through and emitted from the termination 122 t of the delivery fiber 122 is redirected by a delivery mirror 124 towards the vessel, e.g., arterial, wall 104 .
- a collection mirror 126 redirects light 127 scattered or reflected from various depths of the arterial wall 104 into a distal end 123 t of the collection fiber 123 .
- a focusing element serves to collect the diverging optical beam from optical fiber 122 and refocus the beam into the vessel wall.
- Suitable focusing elements may include a gradient indexed lens, micro-optical lens, a grating or a curved mirror.
- a single fiber or fiber bundle may function as both a delivery and a collection waveguide.
- the at least one delivery fiber 122 is a single mode optical fiber that propagates only a single spatial mode within the fiber at the wavelengths of interest.
- the collection fiber 123 is multimode fiber having a core diameter of approximately 60 micrometers or larger, including diameters to about 200 micrometers or larger.
- the single mode delivery fiber is used with light generated by a tunable laser.
- the delivery fiber is used to couple light both to the vessel walls 104 and back to the interferometer for OCT analysis.
- the large core of the collection fiber and higher numerical aperture improves collection efficiency for NIR, Raman, and/or fluorescence spectroscopic analysis.
- other suitable sources of optical radiation such as a super luminescent light-emitting diode (“SLED”), may be used instead of or in addition to the tunable laser.
- SLED super luminescent light-emitting diode
- the ultrasound transducer system 120 includes one or more transducers that direct ultrasound energy 130 towards the arterial wall 104 and receive ultrasound energy 132 reflected from the arterial wall 104 .
- the ultrasound transducer system is longitudinally adjacent to the optical bench 118 .
- the ultrasound system may be located at substantially the same longitudinal position as the distal end(s) of the delivering and collection fiber(s), offset from the fiber(s), for example, by 180 degrees.
- a single ultrasound transducer both generates the transmitted energy 130 and received reflected energy 132 into an electrical signal carried on wires 128 .
- an electrical signal carried on wires 128 actuates the ultrasound transducer 120 to emit a corresponding ultrasound signal 130 .
- the ultrasound transducer 120 produces an electrical signal carried on wires 128 . This electrical signal corresponds to the received ultrasound signal 132 .
- the received signal 132 is used by this IVUS analysis modality to determine the distance D(wall) between the head or distal end of the scanning catheter 112 and the vessel wall 104 and to determine the physical morphology, or structure, of the vessel wall itself.
- the received signal 132 may be useful for characterizing atherosclerotic plaques, including plaque volume in the blood vessel wall and also the degree of stenosis of the blood vessels.
- the ultrasound signal is generated photo-acoustically by sending a light pulse through optical fiber 122 with enough energy to create an acoustic event that is detected by the ultrasound transducer system 120 .
- a transmission medium 134 such as saline or other fluid, surrounding the ultrasound transducer system 120 to facilitate acoustic transmission.
- the transmission medium 134 is also selected to be transparent to the near infrared light emitted from and received by the optical bench 118 .
- a torque cable 136 is attached to a scanning catheter core 116 and surrounds the optical fibers 122 , 123 and the wires 128 .
- This torque cable 136 transmits the torque from a pullback and rotation system through to the scanning catheter head 112 . This feature enables the scanning catheter head 112 to rotate within sheath 114 to circumferentially scan the arterial wall 104 with light 125 and ultrasound energy 130 .
- the catheter head 112 comprises an internal element 150 of a position detection system.
- the internal element 150 communicates with an external element 152 , typically outside the patient's body, in order to determine the position of the catheter tip 112 relative to the external element 152 .
- the internal element is a sensor that detects a field, e.g., magnetic, generated by the external element 152 .
- the detected position information is transmitted on wires 128 and is received by controller 300 , as shown in FIG. 2 .
- a position detection system developed by Mediguide Ltd. for guidewires and coronary catheterization devices could be used.
- the technology provides realtime position information. It uses a small sensor located in the device that is able to determine its position within a magnetic field created around the patient. In this way, additional position information is available, beyond that which would typically be provided from X-ray angiogram images.
- FIG. 2 illustrates an exemplary system for supporting multiple diagnostic catheter functions.
- the system generally comprises the catheter 100 , a controller 300 , and a user interface 320 .
- the catheter 100 are inserted into the patient 2 via a guide catheter (not shown) already placed in a peripheral vessel, such as the femoral artery 10 .
- the catheter tip 112 is then moved to a desired target region, such as a coronary artery 18 of the heart 16 or the carotid artery 14 . This is achieved by moving the catheter 100 up through the aorta 12 , riding on the guidewire 108 .
- the pullback and rotation unit 105 When at the desired site, the pullback and rotation unit 105 is used both for the mechanical drive to the scanning catheter 112 and also to couple optical and electrical signals to and from the catheter 100 . Specifically, the pullback and rotation unit 105 drives the scanning catheter core 116 to rotate and withdraw through the outer sheath 114 .
- An exemplary pullback and rotation unit is disclosed in U.S. pat. appl. Ser. No. 11/875,590, filed on Oct. 19, 2007, entitled Optical Catheter Carriage Interlock System and Method (U.S. Patent Application Pub. No. 2008-0097223), which is incorporated herein by this reference in its entirety.
- This disclosed pullback and rotation unit shows an optical layout in which the tunable signal from a tunable laser is coupled onto a rotating and translating drum via a rotary fiber optical joint (FORJ). Returning NIR signals are detected on the drum. Additional detectors are provided for common mode rejection of noise generated in the FORJ.
- FORJ rotary fiber optical joint
- the IVUS subsystem 312 and the optical subsystem 310 are activated during each pullback cycle to generate appropriate signals for transmission through the catheter 100 and receive, detect, preprocess and digitize signals returned from the vessel walls 104 .
- a tunable laser—or other suitable source of optical radiation in the optical subsystem generates a narrowband optical signal that is wavelength scanned over a range in the NIR, covering one or more spectral bands of interest.
- the IVUS subsystem 312 is enabled to simultaneously generate ultrasound images of the vessel walls 104 .
- the returning light is transmitted back down multimode collection fiber 123 of the catheter 100 .
- the returning radiation is provided to the optical subsystem 310 , which can comprise one or multiple optical detectors or spectrometers.
- Light returning on delivery fiber 122 is also analyzed, for example in an interferometer, in order to perform OCT analysis.
- the optical analysis subsystem 310 collects, preprocesses, digitizes and passes raw spectral and OCT to the computer 117 for further processing, analysis and display information to the user interface 320 .
- the IVUS subsystem 312 collects, preprocesses, digitizes and passes the information from the ultrasound transducer 120 to the computer 117 for further processing, analysis and display formation to the user interface 320 .
- the IVUS subsystem 312 comprises the drive electronics for driving the ultrasound transducer 120 and analyzing the response of the transducer 120 to determine the structural measure of interest in an IVUS-type system.
- the computer 117 receives preprocessed, digitized raw IVUS, OCT and NIR data, performs additional processing, scan conversion and data registration and presents one or more representations of the morphological and chemical structure of the vessel walls to the operator via interface 320 , as images and/or data maps.
- the computer 117 may combine the structural analysis information from the IVUS subsystem 312 with information from the optical analysis subsystem 310 . For example, information from both systems is combined into hybrid images displayed to the operator on user interface 320 .
- the information from the IVUS and/or OCT analysis is used to improve the NIR analysis as described in U.S. appl. Ser. No. 12/062,188, filed Apr.
- the collected spectral response may be used to determine whether each region of interest of the blood vessel wall 104 comprises a lipid pool or lipid-rich atheroma, a disrupted plaque, a vulnerable plaque or thin-cap fibroatheroma (TCFA), a fibrotic lesion, a calcific lesion, and/or normal tissue as described in U.S. Pat. Publ. Nos. US 2004/0024298-A1 and US-2005/0228295-A1, which are incorporated herein by this reference in their entirety.
- TCFA thin-cap fibroatheroma
- FIGS. 3-7 illustrate different embodiments of the pullback and rotation unit 105 and a console 106 and how components of the optical subsystem 310 , IVUS subsystem 312 , and computer 117 are distributed between the pullback and rotation unit 105 and console 106 .
- FIG. 3 illustrates embodiment 1.
- the proximal portion of the catheter 100 connects or interfaces with the pullback and rotation unit 105 .
- the sheath 114 connects to the stationary housing 410 of the unit 105 .
- the core 116 connects to a drum unit 408 that drives the rotation of the core 116 , see arrow 412 , and the longitudinal movement of the core 116 relative to the sheath 114 , see arrow 414 .
- the drum 408 includes a slip ring/FORJ assembly 420 that couples electrical and optical signals between the rotating drum 408 and the stationary components of the console 106 .
- the slip rings support the electrical connections and the FORT supports one or more optical connects across the rotating interface.
- control and communication electrical connections 422 are provided between computer 117 and the drum, along with data connections 424 .
- Optical connections 426 are provided between the drum 408 and an NIR/OCT source and interferometer unit 428 of the optical subsystem 310 .
- power is provided to the drum 408 by a D.C. power supply 430 on connection 432 .
- the computer 117 also controls the NIR/OCT source and interferometer unit 428 of the console.
- the power supply 430 powers the NIR/OCT source and interferometer unit 428 and the computer 117 .
- the components supporting the OCT analysis are provided in the NIR/OCT source and interferometer unit 428 of the console 106 .
- the light returning on the collection fiber 123 of the catheter 100 is detected on a detector 442 of the optical subsystem 310 on drum 408 .
- the electrical components of the IVUS system are similarly located on the drum 408 , including the transceiver electronics 440 of the IVUS subsystem 312 .
- the data generated by the IVUS analysis and the NIR analysis is transmitted electrically to the computer via the slip rings on connection 424 .
- the FORJ 420 connects the delivery fiber 122 of the catheter 100 to the OCT source and interferometer 428 , which includes reference arm, a tunable laser, coupler/beamsplitter and an OCT detector such as a balanced detection system.
- optical radiation in the near infrared (NIR) spectral regions is used for both the OCT and NIR analysis, being generated by the tunable laser of unit 428 .
- Exemplary scan bands include 1000 to 1450 nanometers (nm) generally, or 1000 nm to 1350 nm, 1150 nm to 1250 nm, 1175 nm to 1280 nm, and 1190 nm to 1250 nm, more specifically.
- Other exemplary scan bands include 1660 nm to 1740 nm, and 1630 nm to 1800 nm.
- FIG. 4 shows embodiment 2, which differs from embodiment 1 in a number of respects.
- the IVUS transceiver 440 of the IVUS subsystem 312 is located on the console 106 .
- the slip ring electrical connections must support the transmission of radio frequency signals on connection 450 between the transceiver 440 and the drum 408 .
- this embodiment would be compatible with the pullback and rotation unit described in incorporated application Ser. No. 12/062,188, with minor modifications to support the RF connections for the IVUS subsystem.
- FIG. 5 shows embodiment 3, which differs from embodiment 1 in a number of respects.
- the NIR/OCT source and interferometer unit 428 utilizes a broadband source, instead of the tunable laser embodiment 1.
- the source is a superluminescent light emitting diode (SLED).
- a spectrometer spectrograph/detector system 460 is provided, in the console 106 , in this example.
- This configuration of the optical subsystem 310 requires a two optical channel FORJ 420 , channel 426 associated with the delivery fiber 122 and channel 462 associated with the collection optical fiber 123 .
- dual channel FORJ components are offered, for example, by Princetel, Inc. (product number MS2-155-28).
- the spectrograph 460 is preferably a high speed device to support high speed scanning of the vessel walls at about 300 frames/second, simultaneously with the OCT analysis, in some implementations.
- an InGaAs detector array from Hamamatsu Photonics K.K. is used in combination with a Horiba Jobin Yvon Inc. grating, which disperses the spectrum over the detector array.
- FIG. 6 shows embodiment 4 which differs from embodiment 3 in that the OCT source is not used for the NIR analysis.
- an NIR SLED optical source 470 in provided on the drum 408 .
- Light from the NIR source is combined with OCT light from the OCT source and interferometer unit 428 on a single delivery fiber, in one example, or two delivery fibers are provided in the catheter 100 , in another example.
- Light returning on the collection fiber 123 is coupled off the drum 408 through a dual channel FORJ 420 to spectrograph 460 .
- This system has advantages in that the source for the OCT and NIR can be individually optimized for each analysis, possibly operating at different wavelength scan speeds and in different scan bands.
- FIG. 7 shows embodiment 5, which is similar to embodiment 4, but includes the capability for Raman and/or fluorescence analysis. Specifically, it includes a Raman and fluorescence excitation source 482 .
- the Raman/fluorescence laser source 482 is a relatively high power laser and is usually a single frequency laser or laser with only limited wavelength scanning.
- the Raman process is a weak and non-linear process. Thus, high excitation powers are preferably used, but below the damage threshold for the tissue of the vessel walls 104 .
- the light from this Raman source 482 is selectively coupled onto the delivery fiber via optical switch 480 .
- a wavelength multiplexer is used in place of the switch 482 when the optical bands of the OCT and NIR systems 428 do not overlap with the wavelength band of the light from the excitation source 482 .
- this embodiment adds Raman and/or fluorescence analysis to NIR and OCT modalities.
- the IVUS information and the optical analysis information are produced during the same or different scans of the scanning catheter 112 .
- the optical information 410 produced by the NIR and OCT analysis, and IVUS information produced by the IVUS analysis are captured simultaneously while withdrawing and rotating the scanning catheter 112 through the blood vessels 104 , in the same pullback cycle of the pullback and rotation unit 105 .
- the optical information 410 produced by the NIR analysis and IVUS information produced by the IVUS subsystem are captured during the same pullback and rotation operations of the scanning catheter 112 but the OCT analysis is performed in its own dedicated pullback cycle.
- optical information data set produced by the NIR analysis and IVUS data set are spatially aligned with the OCT data set, with respect to each other.
- This alignment further includes compensation for the offset distance D(offset) between the IVUS transducer 120 and the optical bench 118 , see FIG. 1 .
- the NIR analysis is first performed over the entire length of the artery of interest. This leverages an advantage of the NIR analysis: neither occlusion nor a saline flush is necessary since the analysis can be performed through the flowing blood. This initial NIR analysis is used to identify regions of the artery that require further analysis via OCT. Another advantage associated with serial scanning arises from the fact that the OCT analysis is typically performed at higher scanning speeds in terms of the rotation speed of the catheter and the rate of pullback through the artery. Thus when NIR and OCT are performed during separate scans, optimal speeds can be used for both modalities. Another advantage is that the OCT is performed only at selected locations and thus the length of time and volume of the concomitant saline flush is minimized and kept within clinically appropriate limits.
- any IVUS scan typically takes longer than the OCT scan since it uses slower rotation speeds and pullback speeds than the OCT.
- the OCT scan is completed with about 4-5 seconds, which is the window provided by a 20 cc saline flush.
- the disclosed system provides advantages in that only a single catheter must be inserted in the patient, decreasing risk to the patient and lowering the time required for the invasive portions of the procedure.
- a final key consideration in the “fusing” of image data obtained from different modalities is the accurate spatial co-registration (longitudinal and rotational) of the images. Having one catheter that incorporates multiple invasive imaging modalities provides a fixed frame of reference that greatly facilitates co-registration. This registration is further improved by using the position detection system including the internal element 150 and external element 152 .
Abstract
Methods, apparatus, and systems for intravascular analysis combine at least three analytical modalities. In one implementation, intravascular ultrasound, optical coherence tomography, and near infrared spectroscopy are combined to enable detection of multiple, different abnormalities in the arterial morphology during a single intravascular procedure.
Description
- This application is a continuation of U.S. application Ser. No. 12/437,022 (filed May 7, 2009), which claims the benefit under 35 U.S.C. 119(e) of U.S. Provisional Application Ser. No. 61/051,227, filed May 7, 2008, the disclosure of which is hereby incorporated by reference.
- Atherosclerosis is a vascular disease characterized by the modification of the walls of blood carrying vessels. This modification can take the form of thickening of the vessel wall, eventually forming what are commonly referred to as “plaques.” The mechanisms corresponding to the formation, progression, stabilization, or rupture of these plaques and their effects on humans has been an area of intense research in intravascular medicine. With the advent of interventional cardiology and percutaneous diagnostic and treatment procedures, the patient with coronary atherosclerotic disease was no longer required to automatically submit to coronary by-pass surgery—an extremely invasive procedure with attendant risks and extended recovery time. Coronary stents were developed to revascularize narrowed (stenosed) vessels and millions of theses devices have been placed in patients worldwide. However, current statistics show that, while patient comfort and quality of life has been improved, treatment of coronary atherosclerotic disease by stenting has not significantly reduced the patient mortality. Patients treated with stents are still dying suddenly of heart attack.
- Much more is now known about coronary disease than even a decade ago, but there are still many questions to be answered. From retrospective autopsy studies on heart attack victims, it has been shown (ref Virmani) that there is often a portion of the coronary artery tree that is completely blocked by a thrombosis, or blood clot. The thrombosis is typically in the vicinity of a plaque in the vessel wall. Referred to as the “culprit lesion,” it would be this blockage that would cut off the blood supply to a portion of the heart, resulting in death of heart muscle tissue and possibly death of the individual. Certain plaques contain material which, when it comes into contact with blood, causes thrombogenesis, or clot formation.
- These plaques seem to have formed a reservoir, or core, of thrombogenic material behind a layer of fibrous tissue (“cap”), analogous to an abscess. Through some process or set of processes, the integrity of the fibrous layer can become compromised, whereby blood can eventually come into contact with the thrombogenic core. This can be a sudden event, where the patient had no prior warning or even symptoms. If one categorizes plaques broadly as stable—where they may still progress slowly and eventually restrict the vessel—and unstable—those that can change their status rapidly, among the key questions is: “How can we tell the difference?”
- Historically, the search for atherosclerotic disease has been a search for the narrowing in the opening or “lumen” of the vessel. Angiography is one of the oldest intravascular technologies employed for this purpose. The technique typically employs a catheter, introduced percutaneously into the vasculature, that is used to inject a contrast agent, consisting of a radio opaque dye, into the blood vessels of interest. Using x-rays, a two dimensional live (cine) or still image of the vasculature can be obtained. The vessel lumen is visible wherever the contrast agent is able to flow. From these images, one can determine the size of the lumen and the presence of any narrowing or blockage. The presence of a plaque can sometimes be inferred by a diffuse lumen boundary. Despite being standard of care for many years and forming the basis for most therapy decisions, angiography alone suffers from some limitations. First, vessel narrowing is not necessarily rotationally isotropic. With only a single view angle from which to form the 2-D image, areas of narrowing can be underestimated or missed entirely. To obtain images from multiple viewpoints requires more time and exposure of the patient to contrast and x-rays. The nature of the image as a “lumenogram,” along with limited spatial resolution, make it difficult, if not impossible, to make any statement about the characteristics of the tissue in the vessel wall. For example, it is impossible to distinguish between a fibrotic plaque and one with a necrotic, lipid filled core.
- Intravascular ultrasound (IVUS) has emerged, in the last 15 years, as an imaging technology to measure tissue structural characteristics, in particular for blood vessels. IVUS employs a specially designed catheter, with an acoustic transducer at the distal tip, to send and receive ultrasonic signals. So called, “mechanical” IVUS catheters consist of a flexible polymer outer sheath, inside of which is a core that rotates and pulls back through the vessel, generating a series of circumferential scans of the vessel wall. The core typically consists of an RF transmission line, connecting the transducer at the distal tip to drive and receive electronics. A helically wound wire cable is typically used to transmit torque from a rotary motor, through the core to the distal tip, to ensure rotation of the tip with consistent angular velocity. Ultrasonic waves are back scattered by human tissue. The strength of the back scatter is a function of tissue properties, including density. The signal returning from tissue from a rotating IVUS catheter can be represented as a radar plot with a 360 degree view of a section of the vessel and the radial dimension showing the strength of the signal return as a function of distance from the center of the catheter. An advantage of IVUS is that it allows one to obtain an image of the inner walls of the vessel, even through intervening blood. With axial image resolution of 100-200 microns and imaging depth of greater than 5 mm, various structures within the vessel wall can be visualized, including areas of calcification and thickening of the arterial wall. Also, the boundary between the lumen and the vessel intima as well as that between the media and the adventitia can be visualized with accuracy good enough to calculate lumen dimensions and the area of plaques, or “plaque burden.”
- Optical coherence tomography (OCT) is an emerging technology that also provides structural information similar to IVUS. OCT depends on the scattering of light by tissue and uses the coherence properties of light, for example, using a Michelson interferometer, to determine the distance at which a scattering event occurred. The technique is similar to IVUS in that a catheter is moved over a guidewire into the blood vessel to a region of interest and then the core of the catheter is pulled back to scan the artery. However, there are several key differences. For example, the OCT signal cannot penetrate blood, requiring that the blood be cleared from the area of the vessel being imaged. A variety of methods have been employed to accomplish this, the most promising and least dangerous to the patient being a non-occlusive flush, using a bolus of saline/contrast mix. This method provides several seconds in which to obtain an image of a vessel segment.
- Another class of intravascular analysis systems uses chemical analysis modalities. These approaches generally rely on optical spectral analysis including near infrared (NIR), Raman, and fluorescence spectral analysis.
- Near Infrared Spectroscopy (NIR or NIRS) is a technique, again using light in the near infrared region of the spectrum, intended not to image the physical structure of the artery, but the chemical constituents, specifically cholesterol, of the arterial wall. Unlike OCT, NIR can perform such measurement through blood. Operation of a NIR catheter is very similar to that of IVUS with regard to insertion into the patient and pullback and acquisition of data. The result is a two dimensional map of the cholesterol, or lipid, content of the artery.
- NIRS utilizes an intravascular optical catheter which, similarly to IVUS, is driven by a pullback and rotation unit that simultaneously rotates the catheter head around its longitudinal axis while withdrawing the catheter head through the region of the blood vessel of interest.
- During this pullback operation, the spectral response of the inner vessel walls is acquired in a raster scan operation. This provides a spatially-resolved spectroscopic analysis of the region of interest. The strategy is that by determining the spectroscopic response of blood vessel walls, the chemical constituents of those blood vessel walls can be determined by application of chemometric analysis, for example.
- In Raman spectral analysis, the inner walls of the blood vessel are illuminated by a narrow band, such as laser, signal. The Raman spectral response is then detected. This response is generated by the inelastic collisions betweens photons and the chemical constituents in the blood vessel walls. This similarly produces chemical information for the vessel walls.
- Hybrid IVUS/optical catheters have been proposed. For example, in U.S. Pat. No. 6,949,072, which in incorporated herein by this reference in its entirety, a “device for vulnerable plaque detection” is disclosed. Specifically, this patent is directed to intravascular probe that includes optical waveguides and ports for the near infrared analysis of the blood vessel walls while simultaneously including an ultrasound transducer in the probe in order to enable IVUS analysis of the blood vessel walls.
- Aspects of the invention relate to systems, methods, and apparatus for combining three or more intravascular analysis modalities—and thereby exploiting the different diagnostic information available from each modality—in a single intravascular procedure.
- Thus, the present invention concerns multimodal intravascular analysis. In one embodiment, a single catheter combines multiple diagnostic modalities, such as 3, 4 or even 5 diagnostic modalities. In some examples, two or more of the diagnostic modalities are used simultaneously, even during the same pullback and rotation cycle. In other examples, the modalities are employed serially in separate pullback and rotation cycles.
- In general, providing catheter systems that yield chemical information, such as from NIR, Raman, and/or fluorescence spectroscopic analysis, along with other information: lumen dimension (stenosis) and vessel dimension (positive remodeling) and cap thickness (a possible indicator of plaque vulnerability) from IVUS and OCT and fractional flow rate (FFR) from a flow wire, has the potential to increase the likelihood of a positive patient outcome.
- For example, a catheter that combines NIR, IVUS, OCT and a flow wire, provides the physician with a much more comprehensive data set from which to formulate a therapy decision, including stenting, medical therapy, or referral to coronary artery bypass grafting (CABG).
- A further consideration is the “fusing” of image data obtained from different modalities (e.g. angiography, NIR, OCT, IVUS) and the accurate spatial co-registration (longitudinal and rotational) of the images. Having one catheter that incorporates multiple invasive imaging modalities provides a fixed frame of reference that greatly facilitates co-registration, especially when the diagnostic modalities are employed during the same pullback and rotation cycle. Success here is further facilitated by including position detection capabilities in the catheter such as sensors that detect externally-generated signals, magnetic fields, or emitters that generate externally detected signals.
- These and other features, aspects, and advantages of the present invention will become apparent to those skilled in the art after considering the following detailed description, appended claims and accompanying drawings.
- In the accompanying drawings, reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale; emphasis has instead been placed upon illustrating the principles of the invention. Of the drawings:
-
FIG. 1 is a cross-sectional view of an intravascular probe with a guidewire in a distal end of a catheter; -
FIG. 2 is a schematic diagram illustrating the use of the catheter system and a system controller, according to the invention; and -
FIGS. 3-7 are schematic diagrams illustrating embodiments 1-5 having different component layouts between the pullback androtation unit 105 and aconsole 106. - While IVUS analysis provides valuable information regarding certain structural aspects of an arterial wall that enables the practitioner to identify gross structural abnormalities, such as stenosis and other forms of remodeling, IVUS suffers from a number of inherent limitations relevant to the objective of characterizing plaque composition. For this reason, efforts to extend the capability of IVUS to actual characterization of tissue type (e.g. calcific, fibrotic, necrotic) in an effort to differentiate types of plaques and better inform treatment have been largely unsuccessful. Among the inherent limitations of IVUS that limit its efficacy are that calcified regions block the propagation of IVUS radiation. It is not uncommon for a coronary plaque to be covered with a calcific cap, and therefore, such plaque may go undetected in an IVUS analysis. Also, softer plaques, which often contain lipids, are generally hypoechoic. Thus, it is from an absence of signal that one must infer the plaque composition. Use of a null signal to infer plaque properties is not ideal and can be subject to errors.
- OCT, like IVUS, provides information regarding the structural aspects of the arterial wall but has the capability to generate images with up to ten times better resolution than IVUS. This now enables the visualization of structures which cannot be seen with IVUS. In particular, the thickness of the fibrous cap covering a plaque with a necrotic core can now be measured with high precision. However, OCT optical signals are severely attenuated by blood and also have limited penetration in tissue. Not only does this mean that it is necessary to clear blood from the vessel, as mentioned previously, but the imaging depth in tissue achievable with OCT is limited to approximately 1 mm.
- NIRS, as described above, provides information regarding the chemical constitution of the artery to identify the, cholesterol, or lipids content of the artery.
- The inventors have determined that the combination of at least these three diagnostic modalities can significantly enhance the efficacy of the intraluminal analysis. For example, by identifying a variety of arterial abnormalities, such as positive remodeling (best detectable by IVUS), thin caps (best detectable by OCT), and a necrotic core (best detectable by spectroscopy, e.g., NIR), the diagnostic accuracy can be significantly improved. Moreover, by combining at least these three modalities in a single system, apparatus, and method, these multiple informational components used in the diagnosis can be obtained in a single intravascular procedure.
-
FIG. 1 shows an embodiment of anintravascular catheter system 100 that combines multiple diagnostic modalities. - In typical operation, the
intravascular catheter 100 is advanced into ablood vessel 18 using aguidewire 108 that is threaded through theguidewire lumen 110. - The
catheter system 100 further comprises an innerscanning catheter core 116 andouter sheath 114. The combination of thescanning catheter core 116 andsheath 114 enables the innerscanning catheter core 116 and specifically thecatheter tip 112 to perform longitudinal translation (arrow 50) and rotation (arrow 52) while thesheath 114 prevents this movement from damaging thevessel 18 and specificallywalls 104. - The
tip 112 of thescanning catheter core 116 is located at the distal end of thecatheter 100 and includes anoptical bench 118 to transmit and receive light, typically infrared light, and anultrasound transducer system 120 to transmit and receive ultrasound energy. - At least the distal end of the
sheath 114 is composed of materials that are transparent to light, e.g., near infrared, employed by the optical diagnostic modalities (e.g., a polymer) and will also propagate ultrasound used by IVUS. - The
optical bench 118 contains theterminations delivery fiber 122 and at least onecollection fiber 123, which extend between the proximal and distal ends of thecatheter 100.Light 125 propagating through and emitted from thetermination 122 t of thedelivery fiber 122 is redirected by adelivery mirror 124 towards the vessel, e.g., arterial,wall 104. Acollection mirror 126 redirects light 127 scattered or reflected from various depths of thearterial wall 104 into adistal end 123 t of thecollection fiber 123. - In one implementation, a focusing element serves to collect the diverging optical beam from
optical fiber 122 and refocus the beam into the vessel wall. Suitable focusing elements may include a gradient indexed lens, micro-optical lens, a grating or a curved mirror. - In an alternate implementation, a single fiber or fiber bundle may function as both a delivery and a collection waveguide.
- In one implementation, the at least one
delivery fiber 122 is a single mode optical fiber that propagates only a single spatial mode within the fiber at the wavelengths of interest. Thecollection fiber 123 is multimode fiber having a core diameter of approximately 60 micrometers or larger, including diameters to about 200 micrometers or larger. In one embodiment, the single mode delivery fiber is used with light generated by a tunable laser. In this embodiment, the delivery fiber is used to couple light both to thevessel walls 104 and back to the interferometer for OCT analysis. The large core of the collection fiber and higher numerical aperture improves collection efficiency for NIR, Raman, and/or fluorescence spectroscopic analysis. In an alternate implementation, other suitable sources of optical radiation, such as a super luminescent light-emitting diode (“SLED”), may be used instead of or in addition to the tunable laser. - The
ultrasound transducer system 120 includes one or more transducers that directultrasound energy 130 towards thearterial wall 104 and receiveultrasound energy 132 reflected from thearterial wall 104. In one embodiment, the ultrasound transducer system is longitudinally adjacent to theoptical bench 118. In an alternate implementation, the ultrasound system may be located at substantially the same longitudinal position as the distal end(s) of the delivering and collection fiber(s), offset from the fiber(s), for example, by 180 degrees. Using time multiplexing in one implementation, a single ultrasound transducer both generates the transmittedenergy 130 and received reflectedenergy 132 into an electrical signal carried onwires 128. For example, during a first time interval, an electrical signal carried onwires 128 actuates theultrasound transducer 120 to emit acorresponding ultrasound signal 130. Then during a second time interval, after theultrasound signal 130 has reflected from thearterial wall 104, theultrasound transducer 120 produces an electrical signal carried onwires 128. This electrical signal corresponds to the receivedultrasound signal 132. - The received
signal 132 is used by this IVUS analysis modality to determine the distance D(wall) between the head or distal end of thescanning catheter 112 and thevessel wall 104 and to determine the physical morphology, or structure, of the vessel wall itself. For example, the receivedsignal 132 may be useful for characterizing atherosclerotic plaques, including plaque volume in the blood vessel wall and also the degree of stenosis of the blood vessels. - In other embodiments, the ultrasound signal is generated photo-acoustically by sending a light pulse through
optical fiber 122 with enough energy to create an acoustic event that is detected by theultrasound transducer system 120. - Between the
sheath 114 and thecore 116 is atransmission medium 134, such as saline or other fluid, surrounding theultrasound transducer system 120 to facilitate acoustic transmission. Thetransmission medium 134 is also selected to be transparent to the near infrared light emitted from and received by theoptical bench 118. - A
torque cable 136 is attached to ascanning catheter core 116 and surrounds theoptical fibers wires 128. Thistorque cable 136 transmits the torque from a pullback and rotation system through to thescanning catheter head 112. This feature enables thescanning catheter head 112 to rotate withinsheath 114 to circumferentially scan thearterial wall 104 withlight 125 andultrasound energy 130. - In one embodiment, the
catheter head 112 comprises aninternal element 150 of a position detection system. Theinternal element 150 communicates with anexternal element 152, typically outside the patient's body, in order to determine the position of thecatheter tip 112 relative to theexternal element 152. In one embodiment, the internal element is a sensor that detects a field, e.g., magnetic, generated by theexternal element 152. The detected position information is transmitted onwires 128 and is received bycontroller 300, as shown inFIG. 2 . - In one embodiment, a position detection system developed by Mediguide Ltd. for guidewires and coronary catheterization devices could be used. The technology provides realtime position information. It uses a small sensor located in the device that is able to determine its position within a magnetic field created around the patient. In this way, additional position information is available, beyond that which would typically be provided from X-ray angiogram images.
-
FIG. 2 illustrates an exemplary system for supporting multiple diagnostic catheter functions. - The system generally comprises the
catheter 100, acontroller 300, and a user interface 320. - In operation, first the guide wire and then the
catheter 100 are inserted into thepatient 2 via a guide catheter (not shown) already placed in a peripheral vessel, such as thefemoral artery 10. Thecatheter tip 112 is then moved to a desired target region, such as acoronary artery 18 of theheart 16 or thecarotid artery 14. This is achieved by moving thecatheter 100 up through theaorta 12, riding on theguidewire 108. - When at the desired site, the pullback and
rotation unit 105 is used both for the mechanical drive to thescanning catheter 112 and also to couple optical and electrical signals to and from thecatheter 100. Specifically, the pullback androtation unit 105 drives thescanning catheter core 116 to rotate and withdraw through theouter sheath 114. An exemplary pullback and rotation unit is disclosed in U.S. pat. appl. Ser. No. 11/875,590, filed on Oct. 19, 2007, entitled Optical Catheter Carriage Interlock System and Method (U.S. Patent Application Pub. No. 2008-0097223), which is incorporated herein by this reference in its entirety. This disclosed pullback and rotation unit shows an optical layout in which the tunable signal from a tunable laser is coupled onto a rotating and translating drum via a rotary fiber optical joint (FORJ). Returning NIR signals are detected on the drum. Additional detectors are provided for common mode rejection of noise generated in the FORJ. - The IVUS subsystem 312 and the
optical subsystem 310 are activated during each pullback cycle to generate appropriate signals for transmission through thecatheter 100 and receive, detect, preprocess and digitize signals returned from thevessel walls 104. In a preferred embodiment, a tunable laser—or other suitable source of optical radiation—in the optical subsystem generates a narrowband optical signal that is wavelength scanned over a range in the NIR, covering one or more spectral bands of interest. The same or a different laser—or other suitable source of optical radiation—is used to generate signals for OCT analysis of the vessel walls. At the same time, the IVUS subsystem 312 is enabled to simultaneously generate ultrasound images of thevessel walls 104. - In one embodiment, the returning light is transmitted back down
multimode collection fiber 123 of thecatheter 100. The returning radiation is provided to theoptical subsystem 310, which can comprise one or multiple optical detectors or spectrometers. Light returning ondelivery fiber 122 is also analyzed, for example in an interferometer, in order to perform OCT analysis. - The
optical analysis subsystem 310 collects, preprocesses, digitizes and passes raw spectral and OCT to thecomputer 117 for further processing, analysis and display information to the user interface 320. - The IVUS subsystem 312 collects, preprocesses, digitizes and passes the information from the
ultrasound transducer 120 to thecomputer 117 for further processing, analysis and display formation to the user interface 320. - In more detail, the IVUS subsystem 312 comprises the drive electronics for driving the
ultrasound transducer 120 and analyzing the response of thetransducer 120 to determine the structural measure of interest in an IVUS-type system. - Generally, the
computer 117 receives preprocessed, digitized raw IVUS, OCT and NIR data, performs additional processing, scan conversion and data registration and presents one or more representations of the morphological and chemical structure of the vessel walls to the operator via interface 320, as images and/or data maps. Thecomputer 117 may combine the structural analysis information from the IVUS subsystem 312 with information from theoptical analysis subsystem 310. For example, information from both systems is combined into hybrid images displayed to the operator on user interface 320. In further examples, the information from the IVUS and/or OCT analysis is used to improve the NIR analysis as described in U.S. appl. Ser. No. 12/062,188, filed Apr. 3, 2008, entitled: System and Method for Intravascular Structural Analysis Compensation of Chemical Analysis Modality, which is incorporated herein by this reference in its entirety. The collected spectral response may be used to determine whether each region of interest of theblood vessel wall 104 comprises a lipid pool or lipid-rich atheroma, a disrupted plaque, a vulnerable plaque or thin-cap fibroatheroma (TCFA), a fibrotic lesion, a calcific lesion, and/or normal tissue as described in U.S. Pat. Publ. Nos. US 2004/0024298-A1 and US-2005/0228295-A1, which are incorporated herein by this reference in their entirety. -
FIGS. 3-7 illustrate different embodiments of the pullback androtation unit 105 and aconsole 106 and how components of theoptical subsystem 310, IVUS subsystem 312, andcomputer 117 are distributed between the pullback androtation unit 105 andconsole 106. -
FIG. 3 illustratesembodiment 1. Like the other embodiments discussed below, the proximal portion of thecatheter 100 connects or interfaces with the pullback androtation unit 105. Specifically, thesheath 114 connects to thestationary housing 410 of theunit 105. Thecore 116 connects to adrum unit 408 that drives the rotation of thecore 116, seearrow 412, and the longitudinal movement of thecore 116 relative to thesheath 114, seearrow 414. - The
drum 408 includes a slip ring/FORJ assembly 420 that couples electrical and optical signals between therotating drum 408 and the stationary components of theconsole 106. The slip rings support the electrical connections and the FORT supports one or more optical connects across the rotating interface. In more detail, control and communicationelectrical connections 422 are provided betweencomputer 117 and the drum, along withdata connections 424.Optical connections 426 are provided between thedrum 408 and an NIR/OCT source andinterferometer unit 428 of theoptical subsystem 310. Finally, power is provided to thedrum 408 by aD.C. power supply 430 onconnection 432. - The
computer 117 also controls the NIR/OCT source andinterferometer unit 428 of the console. Thepower supply 430 powers the NIR/OCT source andinterferometer unit 428 and thecomputer 117. - In
embodiment 1, the components supporting the OCT analysis are provided in the NIR/OCT source andinterferometer unit 428 of theconsole 106. This includes a tunable laser that tunes the scan band for the NIR analysis. The light returning on thecollection fiber 123 of thecatheter 100 is detected on adetector 442 of theoptical subsystem 310 ondrum 408. The electrical components of the IVUS system are similarly located on thedrum 408, including thetransceiver electronics 440 of the IVUS subsystem 312. The data generated by the IVUS analysis and the NIR analysis is transmitted electrically to the computer via the slip rings onconnection 424. - The
FORJ 420 connects thedelivery fiber 122 of thecatheter 100 to the OCT source andinterferometer 428, which includes reference arm, a tunable laser, coupler/beamsplitter and an OCT detector such as a balanced detection system. - In the operation of
embodiment 1, optical radiation in the near infrared (NIR) spectral regions is used for both the OCT and NIR analysis, being generated by the tunable laser ofunit 428. Exemplary scan bands include 1000 to 1450 nanometers (nm) generally, or 1000 nm to 1350 nm, 1150 nm to 1250 nm, 1175 nm to 1280 nm, and 1190 nm to 1250 nm, more specifically. Other exemplary scan bands include 1660 nm to 1740 nm, and 1630 nm to 1800 nm. -
FIG. 4 showsembodiment 2, which differs fromembodiment 1 in a number of respects. Specifically, in this embodiment, theIVUS transceiver 440 of the IVUS subsystem 312 is located on theconsole 106. Thus the slip ring electrical connections must support the transmission of radio frequency signals onconnection 450 between thetransceiver 440 and thedrum 408. As a result, this embodiment would be compatible with the pullback and rotation unit described in incorporated application Ser. No. 12/062,188, with minor modifications to support the RF connections for the IVUS subsystem. -
FIG. 5 showsembodiment 3, which differs fromembodiment 1 in a number of respects. In this embodiment, the NIR/OCT source andinterferometer unit 428 utilizes a broadband source, instead of thetunable laser embodiment 1. In a preferred embodiment, the source is a superluminescent light emitting diode (SLED). - Thus, to resolve the NIR spectral response of the vessels, a spectrometer spectrograph/
detector system 460 is provided, in theconsole 106, in this example. This configuration of theoptical subsystem 310 requires a twooptical channel FORJ 420,channel 426 associated with thedelivery fiber 122 andchannel 462 associated with the collectionoptical fiber 123. Such dual channel FORJ components are offered, for example, by Princetel, Inc. (product number MS2-155-28). - The
spectrograph 460 is preferably a high speed device to support high speed scanning of the vessel walls at about 300 frames/second, simultaneously with the OCT analysis, in some implementations. In one embodiment, an InGaAs detector array from Hamamatsu Photonics K.K. is used in combination with a Horiba Jobin Yvon Inc. grating, which disperses the spectrum over the detector array. -
FIG. 6 showsembodiment 4 which differs fromembodiment 3 in that the OCT source is not used for the NIR analysis. Specifically, in this example, an NIR SLEDoptical source 470 in provided on thedrum 408. Light from the NIR source is combined with OCT light from the OCT source andinterferometer unit 428 on a single delivery fiber, in one example, or two delivery fibers are provided in thecatheter 100, in another example. Light returning on thecollection fiber 123 is coupled off thedrum 408 through adual channel FORJ 420 tospectrograph 460. This system has advantages in that the source for the OCT and NIR can be individually optimized for each analysis, possibly operating at different wavelength scan speeds and in different scan bands. -
FIG. 7 showsembodiment 5, which is similar toembodiment 4, but includes the capability for Raman and/or fluorescence analysis. Specifically, it includes a Raman andfluorescence excitation source 482. The Raman/fluorescence laser source 482 is a relatively high power laser and is usually a single frequency laser or laser with only limited wavelength scanning. The Raman process is a weak and non-linear process. Thus, high excitation powers are preferably used, but below the damage threshold for the tissue of thevessel walls 104. - The light from this
Raman source 482 is selectively coupled onto the delivery fiber viaoptical switch 480. In other examples, a wavelength multiplexer is used in place of theswitch 482 when the optical bands of the OCT andNIR systems 428 do not overlap with the wavelength band of the light from theexcitation source 482. Thus this embodiment adds Raman and/or fluorescence analysis to NIR and OCT modalities. - Serial/Simultaneous NIR/OCT/IVUS Scanning
- Depending on the implementation, the IVUS information and the optical analysis information are produced during the same or different scans of the
scanning catheter 112. For example, in one implementation, theoptical information 410 produced by the NIR and OCT analysis, and IVUS information produced by the IVUS analysis, are captured simultaneously while withdrawing and rotating thescanning catheter 112 through theblood vessels 104, in the same pullback cycle of the pullback androtation unit 105. In other implementations, theoptical information 410 produced by the NIR analysis and IVUS information produced by the IVUS subsystem are captured during the same pullback and rotation operations of thescanning catheter 112 but the OCT analysis is performed in its own dedicated pullback cycle. Then the optical information data set produced by the NIR analysis and IVUS data set are spatially aligned with the OCT data set, with respect to each other. This alignment further includes compensation for the offset distance D(offset) between theIVUS transducer 120 and theoptical bench 118, seeFIG. 1 . - In a serial scan implementation protocol, the NIR analysis is first performed over the entire length of the artery of interest. This leverages an advantage of the NIR analysis: neither occlusion nor a saline flush is necessary since the analysis can be performed through the flowing blood. This initial NIR analysis is used to identify regions of the artery that require further analysis via OCT. Another advantage associated with serial scanning arises from the fact that the OCT analysis is typically performed at higher scanning speeds in terms of the rotation speed of the catheter and the rate of pullback through the artery. Thus when NIR and OCT are performed during separate scans, optimal speeds can be used for both modalities. Another advantage is that the OCT is performed only at selected locations and thus the length of time and volume of the concomitant saline flush is minimized and kept within clinically appropriate limits.
- Also, any IVUS scan typically takes longer than the OCT scan since it uses slower rotation speeds and pullback speeds than the OCT. Generally, the OCT scan is completed with about 4-5 seconds, which is the window provided by a 20 cc saline flush.
- Despite the fact that some implementations employ separate scans for the NIR, OCT and IVUS analyses, the disclosed system provides advantages in that only a single catheter must be inserted in the patient, decreasing risk to the patient and lowering the time required for the invasive portions of the procedure.
- A final key consideration in the “fusing” of image data obtained from different modalities (e.g. angiography, NIR, OCT, IVUS) is the accurate spatial co-registration (longitudinal and rotational) of the images. Having one catheter that incorporates multiple invasive imaging modalities provides a fixed frame of reference that greatly facilitates co-registration. This registration is further improved by using the position detection system including the
internal element 150 andexternal element 152. - Thus, exemplary embodiments have been fully described above with reference to the drawing figures. Although the invention has been described based upon these exemplary embodiments, it would be apparent to those of skill in the art that certain modifications, variations, and alternative constructions could be made to the described embodiments within the spirit and scope of the invention.
Claims (14)
1. An intravascular catheter system comprising:
at least one optical fiber configured to transmit optical radiation between distal and proximal ends thereof, wherein said distal end of said optical fiber is in optical communication with an arterial wall;
at least one source of optical radiation optically coupled to a portion of said optical fiber and configured to generate optical radiation to be transmitted by said optical fiber to the arterial wall;
an interferometer optically coupled to a portion of said optical fiber and configured to receive optical radiation transmitted by said optical fiber from the arterial wall and to provide an interference signal for sub-surface imaging of the arterial wall;
an optical processing module optically coupled to a portion of said optical fiber and configured to receive optical radiation transmitted by said optical fiber from the arterial wall and to provide spectroscopic information about the arterial wall from detected intensity of the light collected from the arterial wall;
an ultrasound transducer configured to transmit ultrasound energy toward the arterial wall, receive ultrasound energy reflected from the arterial wall, and convert the received ultrasound energy to an electric signal; and
an ultrasonic subsystem in communication with said ultrasound transducer and configured to generate an ultrasonic image from the electric signal.
2. The intravascular catheter system of claim 1 , wherein said at least one optical fiber comprises a delivery fiber and a collection fiber and wherein said at least one source is optically coupled with a portion of said delivery fiber, said interferometer is optically coupled to a portion of said delivery fiber and configured to receive optical radiation transmitted by said delivery fiber from the arterial wall, and said optical processing module is optically coupled to a portion of said collection fiber and configured to receive optical radiation transmitted by said collection fiber from the arterial wall.
3. The intravascular catheter system of claim 2 , wherein said delivery fiber is a single mode optical fiber configured to propagate only a single spatial mode and said collection fiber comprises a multimode fiber.
4. The intravascular catheter system of claim 1 , further comprising at least one reflector configured to redirect optical radiation from said distal end of said optical fiber toward the arterial wall and to redirect at least a portion of the optical radiation from the arterial wall toward said distal end of said fiber.
5. The intravascular catheter system of claim 1 , wherein said at least one optical radiation source comprises one or both of a tunable laser and a super luminescent light emitting diode.
6. The intravascular catheter system of claim 1 , wherein said ultrasound transducer is configured to employ time multiplexing to both transmit ultrasound energy toward the arterial wall and receive ultrasound energy from the arterial wall.
7. The intravascular catheter system of claim 1 , further comprising one or more wires providing an electrical connection between said ultrasound transducer and said ultrasonic subsystem.
8. The intravascular catheter system of claim 1 , further comprising an outer sheath covering at least a portion of said optical fiber.
9. The intravascular catheter system of claim 8 , further comprising a guide wire coupled to a portion of said sheath and configured to guide movement of said sheath and said optical fiber through an intravascular lumen.
10. The intravascular catheter system of claim 1 , further comprising a position detection system comprising an internal element configured to be inserted into an intravascular lumen along with said optical fiber and an external element disposed outside the intravascular lumen, wherein said internal element and said external element are configured for communication therebetween for locating a position of said internal element relative to said external element.
11. The intravascular catheter system of claim 1 , wherein said at least one optical fiber and said ultrasound transducer comprise a catheter core, and wherein said system further comprises a torque cable coupled to said catheter core and configured to transmit a rotational force to a distal portion of said catheter core.
12. The intravascular catheter system of claim 11 , further comprising a pullback and rotation unit coupled to said torque cable and configured to withdraw and rotate said optical fiber and said ultrasound transducer within an intravascular lumen.
13. The intravascular catheter system of claim 12 , wherein said pullback and rotation unit is further configured to couple optical signals from the rotating optical fiber to the non-rotating optical processing module.
14. The intravascular catheter system of claim 1 , wherein said ultrasound transducer is distally spaced from said distal end of said optical fiber.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/290,438 US20120116214A1 (en) | 2008-05-07 | 2011-11-07 | Multimodal Catheter System and Method for Intravascular Analysis |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5122708P | 2008-05-07 | 2008-05-07 | |
US12/437,022 US8052605B2 (en) | 2008-05-07 | 2009-05-07 | Multimodal catheter system and method for intravascular analysis |
US13/290,438 US20120116214A1 (en) | 2008-05-07 | 2011-11-07 | Multimodal Catheter System and Method for Intravascular Analysis |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/437,022 Continuation US8052605B2 (en) | 2008-05-07 | 2009-05-07 | Multimodal catheter system and method for intravascular analysis |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120116214A1 true US20120116214A1 (en) | 2012-05-10 |
Family
ID=40935497
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/437,022 Active 2030-03-11 US8052605B2 (en) | 2008-05-07 | 2009-05-07 | Multimodal catheter system and method for intravascular analysis |
US13/290,438 Abandoned US20120116214A1 (en) | 2008-05-07 | 2011-11-07 | Multimodal Catheter System and Method for Intravascular Analysis |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/437,022 Active 2030-03-11 US8052605B2 (en) | 2008-05-07 | 2009-05-07 | Multimodal catheter system and method for intravascular analysis |
Country Status (4)
Country | Link |
---|---|
US (2) | US8052605B2 (en) |
EP (1) | EP2273916A1 (en) |
JP (1) | JP2011519689A (en) |
WO (1) | WO2009137659A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2777486A3 (en) * | 2013-03-15 | 2015-04-08 | Lightlab Imaging, Inc. | Apparatus and method of image registration |
WO2018117393A1 (en) * | 2016-12-22 | 2018-06-28 | 원텍 주식회사 | Pullback device |
WO2018117392A1 (en) * | 2016-12-22 | 2018-06-28 | 원텍 주식회사 | Fusion image acquiring system for diagnosis of cardiovascular diseases |
WO2019055739A1 (en) | 2017-09-15 | 2019-03-21 | Infaredx, Inc. | Method of using an imaging catheter with a reinforced section |
KR20190133741A (en) * | 2017-11-28 | 2019-12-03 | 오리오스메디칼 주식회사 | Optical coherence tomography system |
Families Citing this family (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1722669A4 (en) * | 2004-02-27 | 2009-05-27 | Optiscan Pty Ltd | Optical element |
US9867530B2 (en) | 2006-08-14 | 2018-01-16 | Volcano Corporation | Telescopic side port catheter device with imaging system and method for accessing side branch occlusions |
US7935060B2 (en) | 2006-11-08 | 2011-05-03 | Lightlab Imaging, Inc. | Opto-acoustic imaging devices and methods |
EP2129284A4 (en) | 2007-03-08 | 2012-11-28 | Sync Rx Ltd | Imaging and tools for use with moving organs |
US8781193B2 (en) | 2007-03-08 | 2014-07-15 | Sync-Rx, Ltd. | Automatic quantitative vessel analysis |
US9305334B2 (en) | 2007-03-08 | 2016-04-05 | Sync-Rx, Ltd. | Luminal background cleaning |
US11064964B2 (en) | 2007-03-08 | 2021-07-20 | Sync-Rx, Ltd | Determining a characteristic of a lumen by measuring velocity of a contrast agent |
US9968256B2 (en) | 2007-03-08 | 2018-05-15 | Sync-Rx Ltd. | Automatic identification of a tool |
US10716528B2 (en) | 2007-03-08 | 2020-07-21 | Sync-Rx, Ltd. | Automatic display of previously-acquired endoluminal images |
US9629571B2 (en) | 2007-03-08 | 2017-04-25 | Sync-Rx, Ltd. | Co-use of endoluminal data and extraluminal imaging |
US11197651B2 (en) | 2007-03-08 | 2021-12-14 | Sync-Rx, Ltd. | Identification and presentation of device-to-vessel relative motion |
US9375164B2 (en) | 2007-03-08 | 2016-06-28 | Sync-Rx, Ltd. | Co-use of endoluminal data and extraluminal imaging |
US9596993B2 (en) | 2007-07-12 | 2017-03-21 | Volcano Corporation | Automatic calibration systems and methods of use |
WO2009009802A1 (en) | 2007-07-12 | 2009-01-15 | Volcano Corporation | Oct-ivus catheter for concurrent luminal imaging |
EP2178442B1 (en) | 2007-07-12 | 2017-09-06 | Volcano Corporation | Catheter for in vivo imaging |
US9713448B2 (en) | 2008-04-03 | 2017-07-25 | Infraredx, Inc. | System and method for intravascular structural analysis compensation of chemical analysis modality |
WO2009132188A1 (en) * | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Methods, systems, and devices for tissue characterization by spectral similarity of intravascular ultrasound signals |
US9549713B2 (en) * | 2008-04-24 | 2017-01-24 | Boston Scientific Scimed, Inc. | Methods, systems, and devices for tissue characterization and quantification using intravascular ultrasound signals |
ES2450391T3 (en) | 2008-06-19 | 2014-03-24 | Sync-Rx, Ltd. | Progressive progress of a medical instrument |
US9101286B2 (en) | 2008-11-18 | 2015-08-11 | Sync-Rx, Ltd. | Apparatus and methods for determining a dimension of a portion of a stack of endoluminal data points |
US9144394B2 (en) | 2008-11-18 | 2015-09-29 | Sync-Rx, Ltd. | Apparatus and methods for determining a plurality of local calibration factors for an image |
US9095313B2 (en) | 2008-11-18 | 2015-08-04 | Sync-Rx, Ltd. | Accounting for non-uniform longitudinal motion during movement of an endoluminal imaging probe |
US8855744B2 (en) | 2008-11-18 | 2014-10-07 | Sync-Rx, Ltd. | Displaying a device within an endoluminal image stack |
US9974509B2 (en) | 2008-11-18 | 2018-05-22 | Sync-Rx Ltd. | Image super enhancement |
US10362962B2 (en) | 2008-11-18 | 2019-07-30 | Synx-Rx, Ltd. | Accounting for skipped imaging locations during movement of an endoluminal imaging probe |
US11064903B2 (en) | 2008-11-18 | 2021-07-20 | Sync-Rx, Ltd | Apparatus and methods for mapping a sequence of images to a roadmap image |
US8647281B2 (en) | 2009-03-31 | 2014-02-11 | Boston Scientific Scimed, Inc. | Systems and methods for making and using an imaging core of an intravascular ultrasound imaging system |
US8298149B2 (en) | 2009-03-31 | 2012-10-30 | Boston Scientific Scimed, Inc. | Systems and methods for making and using a motor distally-positioned within a catheter of an intravascular ultrasound imaging system |
US8932223B2 (en) * | 2009-11-02 | 2015-01-13 | Board Of Regents, The University Of Texas System | Catheter for intravascular ultrasound and photoacoustic imaging |
US9375255B2 (en) | 2010-11-05 | 2016-06-28 | Ethicon Endo-Surgery, Llc | Surgical instrument handpiece with resiliently biased coupling to modular shaft and end effector |
US10959769B2 (en) | 2010-11-05 | 2021-03-30 | Ethicon Llc | Surgical instrument with slip ring assembly to power ultrasonic transducer |
US20120116381A1 (en) | 2010-11-05 | 2012-05-10 | Houser Kevin L | Surgical instrument with charging station and wireless communication |
US9247986B2 (en) | 2010-11-05 | 2016-02-02 | Ethicon Endo-Surgery, Llc | Surgical instrument with ultrasonic transducer having integral switches |
US9089338B2 (en) | 2010-11-05 | 2015-07-28 | Ethicon Endo-Surgery, Inc. | Medical device packaging with window for insertion of reusable component |
US9017849B2 (en) | 2010-11-05 | 2015-04-28 | Ethicon Endo-Surgery, Inc. | Power source management for medical device |
US9011471B2 (en) | 2010-11-05 | 2015-04-21 | Ethicon Endo-Surgery, Inc. | Surgical instrument with pivoting coupling to modular shaft and end effector |
US9161803B2 (en) | 2010-11-05 | 2015-10-20 | Ethicon Endo-Surgery, Inc. | Motor driven electrosurgical device with mechanical and electrical feedback |
US20120116265A1 (en) | 2010-11-05 | 2012-05-10 | Houser Kevin L | Surgical instrument with charging devices |
US9782214B2 (en) | 2010-11-05 | 2017-10-10 | Ethicon Llc | Surgical instrument with sensor and powered control |
US9782215B2 (en) | 2010-11-05 | 2017-10-10 | Ethicon Endo-Surgery, Llc | Surgical instrument with ultrasonic transducer having integral switches |
US9072523B2 (en) | 2010-11-05 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Medical device with feature for sterile acceptance of non-sterile reusable component |
US10881448B2 (en) | 2010-11-05 | 2021-01-05 | Ethicon Llc | Cam driven coupling between ultrasonic transducer and waveguide in surgical instrument |
US9381058B2 (en) | 2010-11-05 | 2016-07-05 | Ethicon Endo-Surgery, Llc | Recharge system for medical devices |
US9597143B2 (en) | 2010-11-05 | 2017-03-21 | Ethicon Endo-Surgery, Llc | Sterile medical instrument charging device |
US9039720B2 (en) | 2010-11-05 | 2015-05-26 | Ethicon Endo-Surgery, Inc. | Surgical instrument with ratcheting rotatable shaft |
US10660695B2 (en) | 2010-11-05 | 2020-05-26 | Ethicon Llc | Sterile medical instrument charging device |
US9526921B2 (en) * | 2010-11-05 | 2016-12-27 | Ethicon Endo-Surgery, Llc | User feedback through end effector of surgical instrument |
US9649150B2 (en) | 2010-11-05 | 2017-05-16 | Ethicon Endo-Surgery, Llc | Selective activation of electronic components in medical device |
US9017851B2 (en) | 2010-11-05 | 2015-04-28 | Ethicon Endo-Surgery, Inc. | Sterile housing for non-sterile medical device component |
US9421062B2 (en) | 2010-11-05 | 2016-08-23 | Ethicon Endo-Surgery, Llc | Surgical instrument shaft with resiliently biased coupling to handpiece |
US9000720B2 (en) | 2010-11-05 | 2015-04-07 | Ethicon Endo-Surgery, Inc. | Medical device packaging with charging interface |
US9510895B2 (en) | 2010-11-05 | 2016-12-06 | Ethicon Endo-Surgery, Llc | Surgical instrument with modular shaft and end effector |
US10085792B2 (en) | 2010-11-05 | 2018-10-02 | Ethicon Llc | Surgical instrument with motorized attachment feature |
EP3988011B1 (en) | 2010-11-08 | 2023-08-23 | Conavi Medical Inc. | Systems for improved visualization during minimally invasive procedures |
US11141063B2 (en) | 2010-12-23 | 2021-10-12 | Philips Image Guided Therapy Corporation | Integrated system architectures and methods of use |
US20120172698A1 (en) * | 2010-12-30 | 2012-07-05 | Boston Scientific Scimed, Inc. | Imaging system |
US11040140B2 (en) | 2010-12-31 | 2021-06-22 | Philips Image Guided Therapy Corporation | Deep vein thrombosis therapeutic methods |
US9788731B2 (en) * | 2011-02-21 | 2017-10-17 | Jaywant Philip Parmar | Optical endoluminal far-field microscopic imaging catheter |
US9164240B2 (en) | 2011-03-31 | 2015-10-20 | Lightlab Imaging, Inc. | Optical buffering methods, apparatus, and systems for increasing the repetition rate of tunable light sources |
EP2656051B1 (en) * | 2011-05-31 | 2021-11-03 | Lightlab Imaging, Inc. | Multimodal imaging system |
WO2013033489A1 (en) * | 2011-08-31 | 2013-03-07 | Volcano Corporation | Optical rotary joint and methods of use |
EP2779907B1 (en) | 2011-11-16 | 2022-06-15 | Philips Image Guided Therapy Corporation | Medical measuring system and method |
US9237851B2 (en) * | 2012-02-03 | 2016-01-19 | Ninepoint Medical, Inc. | Imaging system producing multiple registered images of a body lumen |
WO2013123014A1 (en) * | 2012-02-14 | 2013-08-22 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System for assessing effects of ablation therapy on cardiac tissue using photoacoustics |
JP6062421B2 (en) * | 2012-03-26 | 2017-01-18 | テルモ株式会社 | Diagnostic imaging apparatus and operating method thereof |
EP2832302B1 (en) * | 2012-03-28 | 2022-08-24 | Terumo Kabushiki Kaisha | Probe |
JP6134789B2 (en) | 2012-06-26 | 2017-05-24 | シンク−アールエックス,リミティド | Image processing related to flow in luminal organs |
US10881459B2 (en) | 2012-07-18 | 2021-01-05 | Bernard Boon Chye Lim | Apparatus and method for assessing tissue treatment |
US9526426B1 (en) | 2012-07-18 | 2016-12-27 | Bernard Boon Chye Lim | Apparatus and method for assessing tissue composition |
US10499984B2 (en) | 2012-07-18 | 2019-12-10 | Bernard Boon Chye Lim | Apparatus and method for assessing tissue treatment |
WO2014049644A1 (en) * | 2012-09-26 | 2014-04-03 | テルモ株式会社 | Corrective jig, image diagnostic device, and image diagnostic device correction method |
US9858668B2 (en) | 2012-10-05 | 2018-01-02 | Volcano Corporation | Guidewire artifact removal in images |
US11272845B2 (en) | 2012-10-05 | 2022-03-15 | Philips Image Guided Therapy Corporation | System and method for instant and automatic border detection |
US9286673B2 (en) * | 2012-10-05 | 2016-03-15 | Volcano Corporation | Systems for correcting distortions in a medical image and methods of use thereof |
US9292918B2 (en) * | 2012-10-05 | 2016-03-22 | Volcano Corporation | Methods and systems for transforming luminal images |
JP2015532536A (en) | 2012-10-05 | 2015-11-09 | デイビッド ウェルフォード, | System and method for amplifying light |
US9324141B2 (en) | 2012-10-05 | 2016-04-26 | Volcano Corporation | Removal of A-scan streaking artifact |
US9367965B2 (en) | 2012-10-05 | 2016-06-14 | Volcano Corporation | Systems and methods for generating images of tissue |
US10568586B2 (en) | 2012-10-05 | 2020-02-25 | Volcano Corporation | Systems for indicating parameters in an imaging data set and methods of use |
US9307926B2 (en) | 2012-10-05 | 2016-04-12 | Volcano Corporation | Automatic stent detection |
US10070827B2 (en) | 2012-10-05 | 2018-09-11 | Volcano Corporation | Automatic image playback |
US9840734B2 (en) | 2012-10-22 | 2017-12-12 | Raindance Technologies, Inc. | Methods for analyzing DNA |
EP2919659B1 (en) | 2012-11-19 | 2021-03-17 | Lightlab Imaging, Inc. | Multimodal imaging systems |
EP2931132B1 (en) | 2012-12-13 | 2023-07-05 | Philips Image Guided Therapy Corporation | System for targeted cannulation |
CA2895502A1 (en) | 2012-12-20 | 2014-06-26 | Jeremy Stigall | Smooth transition catheters |
US11406498B2 (en) | 2012-12-20 | 2022-08-09 | Philips Image Guided Therapy Corporation | Implant delivery system and implants |
US10942022B2 (en) | 2012-12-20 | 2021-03-09 | Philips Image Guided Therapy Corporation | Manual calibration of imaging system |
JP2016506276A (en) | 2012-12-20 | 2016-03-03 | ジェレミー スティガール, | Locate the intravascular image |
US9709379B2 (en) | 2012-12-20 | 2017-07-18 | Volcano Corporation | Optical coherence tomography system that is reconfigurable between different imaging modes |
US10939826B2 (en) | 2012-12-20 | 2021-03-09 | Philips Image Guided Therapy Corporation | Aspirating and removing biological material |
WO2014100606A1 (en) | 2012-12-21 | 2014-06-26 | Meyer, Douglas | Rotational ultrasound imaging catheter with extended catheter body telescope |
EP2934280B1 (en) | 2012-12-21 | 2022-10-19 | Mai, Jerome | Ultrasound imaging with variable line density |
EP2936626A4 (en) | 2012-12-21 | 2016-08-17 | David Welford | Systems and methods for narrowing a wavelength emission of light |
US9486143B2 (en) | 2012-12-21 | 2016-11-08 | Volcano Corporation | Intravascular forward imaging device |
US10191220B2 (en) | 2012-12-21 | 2019-01-29 | Volcano Corporation | Power-efficient optical circuit |
JP6363095B2 (en) * | 2012-12-21 | 2018-07-25 | ボルケーノ コーポレイション | Processing system and method of operating the processing system |
US10413317B2 (en) | 2012-12-21 | 2019-09-17 | Volcano Corporation | System and method for catheter steering and operation |
CA2895940A1 (en) | 2012-12-21 | 2014-06-26 | Andrew Hancock | System and method for multipath processing of image signals |
US10058284B2 (en) | 2012-12-21 | 2018-08-28 | Volcano Corporation | Simultaneous imaging, monitoring, and therapy |
US9612105B2 (en) | 2012-12-21 | 2017-04-04 | Volcano Corporation | Polarization sensitive optical coherence tomography system |
US10332228B2 (en) | 2012-12-21 | 2019-06-25 | Volcano Corporation | System and method for graphical processing of medical data |
US10226597B2 (en) | 2013-03-07 | 2019-03-12 | Volcano Corporation | Guidewire with centering mechanism |
WO2014138555A1 (en) | 2013-03-07 | 2014-09-12 | Bernhard Sturm | Multimodal segmentation in intravascular images |
EP2967391A4 (en) | 2013-03-12 | 2016-11-02 | Donna Collins | Systems and methods for diagnosing coronary microvascular disease |
US20140276923A1 (en) | 2013-03-12 | 2014-09-18 | Volcano Corporation | Vibrating catheter and methods of use |
JP6339170B2 (en) | 2013-03-13 | 2018-06-06 | ジンヒョン パーク | System and method for generating images from a rotating intravascular ultrasound device |
US9301687B2 (en) | 2013-03-13 | 2016-04-05 | Volcano Corporation | System and method for OCT depth calibration |
US11026591B2 (en) | 2013-03-13 | 2021-06-08 | Philips Image Guided Therapy Corporation | Intravascular pressure sensor calibration |
US20140276140A1 (en) * | 2013-03-14 | 2014-09-18 | Volcano Corporation | Systems and Methods for Multi-Modality Medical Data Collection |
US20160030151A1 (en) | 2013-03-14 | 2016-02-04 | Volcano Corporation | Filters with echogenic characteristics |
US10292677B2 (en) | 2013-03-14 | 2019-05-21 | Volcano Corporation | Endoluminal filter having enhanced echogenic properties |
US20140276016A1 (en) * | 2013-03-14 | 2014-09-18 | Volcano Corporation | Flushing for imaging catheters |
US10219887B2 (en) | 2013-03-14 | 2019-03-05 | Volcano Corporation | Filters with echogenic characteristics |
EP3015068A4 (en) * | 2013-08-01 | 2017-06-21 | Sogang University Research Foundation | Device and method for acquiring fusion image |
US10080501B2 (en) * | 2013-10-14 | 2018-09-25 | Volcano Corporation | Intravascular devices, systems, and methods |
KR20150053315A (en) * | 2013-11-07 | 2015-05-18 | 삼성전자주식회사 | Optical probe and Medical imaging apparatus comprising the same |
US10136938B2 (en) | 2014-10-29 | 2018-11-27 | Ethicon Llc | Electrosurgical instrument with sensor |
ES2913531T3 (en) | 2015-04-16 | 2022-06-02 | Gentuity Llc | Micro-optic probes for neurology |
CN107567309A (en) | 2015-05-05 | 2018-01-09 | 波士顿科学国际有限公司 | There are the system and method for the expandable material on ultrasonic image-forming system transducer |
US11154186B2 (en) | 2015-07-31 | 2021-10-26 | University Of Utah Research Foundation | Devices, systems, and methods for imaging and treating a selected tissue |
US10631718B2 (en) | 2015-08-31 | 2020-04-28 | Gentuity, Llc | Imaging system includes imaging probe and delivery devices |
CN108882920A (en) * | 2016-02-13 | 2018-11-23 | 普渡研究基金会 | Optoacoustic conduit and the imaging system for using the optoacoustic conduit |
US20180146856A1 (en) * | 2016-11-30 | 2018-05-31 | iSpectrOm LLC | Multi-modality Dynamic Chemical Imaging of Fresh and Live Biological Tissue |
CN110494076B (en) | 2017-02-01 | 2023-07-21 | 犹他大学研究基金会 | Apparatus and method for mapping cardiac tissue |
KR102391591B1 (en) * | 2017-05-16 | 2022-04-27 | 박연호 | Apparatus for estimating shape of flexible portion and endoscope system comprising the same |
US10895692B2 (en) * | 2017-06-01 | 2021-01-19 | Canon U.S.A., Inc. | Fiber optic rotary joints and methods of using and manufacturing same |
WO2019099418A1 (en) * | 2017-11-15 | 2019-05-23 | The Regents Of The University Of California | Broadband, freeform focusing micro optics for side-viewing imaging catheters |
JP7160935B2 (en) | 2017-11-28 | 2022-10-25 | ジェンテュイティ・リミテッド・ライアビリティ・カンパニー | Imaging system |
KR101965636B1 (en) * | 2017-12-14 | 2019-08-13 | 포항공과대학교 산학협력단 | Apparatus for rotation stabilization and scalability improvement of fusion scanning system and method thereof |
CN108618758A (en) * | 2018-04-27 | 2018-10-09 | 华南师范大学 | Intravascular photoacoustic-optical coherence tomography-near infrared light multi-modality imaging apparatus and method |
US11918761B2 (en) | 2018-09-14 | 2024-03-05 | Infraredx, Inc. | Intravascular imaging catheter system with force error detection and automatic remediation via pullback and rotation for translating and rotating a torque cable in a catheter |
CN109363645B (en) * | 2018-10-29 | 2021-04-13 | 中国科学院上海技术物理研究所 | Human body blood vessel detection method based on laser photoacoustic spectroscopy |
JP2022510272A (en) * | 2018-11-30 | 2022-01-26 | スペクトラウェーブ, インコーポレイテッド | Alternating light sources and methods using them |
KR102299087B1 (en) * | 2019-08-09 | 2021-09-08 | 김 철 환 | Glowing IV and subcutaneous catheters with embedded optic fibers |
WO2021127204A1 (en) * | 2019-12-17 | 2021-06-24 | University Of Utah Research Foundation | Cardiac tissue characterization using catheterized light scattering spectroscopy |
CN114190982A (en) * | 2021-11-03 | 2022-03-18 | 江苏大学 | Ultrasonic flow device for cardiovascular medium flow detection |
CN114903527B (en) * | 2022-04-21 | 2023-06-23 | 深圳市嘉驰机电科技有限公司 | Photoelectric composite slip ring for IVUS and OCT multi-mode imaging system |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6501551B1 (en) * | 1991-04-29 | 2002-12-31 | Massachusetts Institute Of Technology | Fiber optic imaging endoscope interferometer with at least one faraday rotator |
US20050075574A1 (en) * | 2003-09-22 | 2005-04-07 | Simon Furnish | Devices for vulnerable plaque detection |
US20070135887A1 (en) * | 2005-12-12 | 2007-06-14 | Siemensaktiengesellschaft | Catheter device for treating a block-age of a vessel |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916210A (en) | 1990-01-26 | 1999-06-29 | Intraluminal Therapeutics, Inc. | Catheter for laser treatment of atherosclerotic plaque and other tissue abnormalities |
US6134003A (en) | 1991-04-29 | 2000-10-17 | Massachusetts Institute Of Technology | Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope |
US5361768A (en) | 1992-06-30 | 1994-11-08 | Cardiovascular Imaging Systems, Inc. | Automated longitudinal position translator for ultrasonic imaging probes, and methods of using same |
US6763261B2 (en) | 1995-09-20 | 2004-07-13 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
US5928145A (en) | 1996-04-25 | 1999-07-27 | The Johns Hopkins University | Method of magnetic resonance imaging and spectroscopic analysis and associated apparatus employing a loopless antenna |
US5773835A (en) | 1996-06-07 | 1998-06-30 | Rare Earth Medical, Inc. | Fiber optic spectroscopy |
US6296608B1 (en) | 1996-07-08 | 2001-10-02 | Boston Scientific Corporation | Diagnosing and performing interventional procedures on tissue in vivo |
US6016440A (en) | 1996-07-29 | 2000-01-18 | Bruker Analytik Gmbh | Device for infrared (IR) spectroscopic investigations of internal surfaces of a body |
US6697666B1 (en) | 1999-06-22 | 2004-02-24 | Board Of Regents, The University Of Texas System | Apparatus for the characterization of tissue of epithelial lined viscus |
US20020087151A1 (en) | 2000-12-29 | 2002-07-04 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
WO2003017745A2 (en) | 2001-08-23 | 2003-03-06 | Sciperio, Inc. | Architecture tool and methods of use |
US20030236443A1 (en) | 2002-04-19 | 2003-12-25 | Cespedes Eduardo Ignacio | Methods and apparatus for the identification and stabilization of vulnerable plaque |
US20030199747A1 (en) | 2002-04-19 | 2003-10-23 | Michlitsch Kenneth J. | Methods and apparatus for the identification and stabilization of vulnerable plaque |
US6690958B1 (en) | 2002-05-07 | 2004-02-10 | Nostix Llc | Ultrasound-guided near infrared spectrophotometer |
US7689268B2 (en) | 2002-08-05 | 2010-03-30 | Infraredx, Inc. | Spectroscopic unwanted signal filters for discrimination of vulnerable plaque and method therefor |
AU2003286534A1 (en) | 2002-10-21 | 2004-05-13 | The General Hospital Corporation D/B/A Massachusetts General Hospital | Catheter and radiofrequency coil with annular b1 filed |
WO2004073501A2 (en) * | 2003-02-20 | 2004-09-02 | Gutin Mikhail | Optical coherence tomography with 3d coherence scanning |
DE10343808B4 (en) | 2003-09-22 | 2017-06-01 | Siemens Healthcare Gmbh | Medical examination and / or treatment system |
DE10354496B4 (en) | 2003-11-21 | 2011-03-31 | Siemens Ag | Medical examination and / or treatment system |
US20060100529A1 (en) | 2004-02-02 | 2006-05-11 | Siemens Corporate Research Inc. | Combined intra-rectal optical-MR and intra-rectal optical-US device for prostate-, cevix-, rectum imaging diagnostics |
US20050228295A1 (en) | 2004-04-01 | 2005-10-13 | Infraredx, Inc. | Method and system for dual domain discrimination of vulnerable plaque |
JP5623692B2 (en) * | 2004-11-02 | 2014-11-12 | ザ ジェネラル ホスピタル コーポレイション | Optical fiber rotator, optical system and method for sample imaging |
US7860555B2 (en) | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue visualization and manipulation system |
JP4577504B2 (en) * | 2005-03-31 | 2010-11-10 | 富士フイルム株式会社 | Diagnostic imaging equipment |
DE102005045373A1 (en) * | 2005-09-22 | 2007-04-05 | Siemens Ag | catheter device |
US7450241B2 (en) | 2005-09-30 | 2008-11-11 | Infraredx, Inc. | Detecting vulnerable plaque |
US20090203991A1 (en) | 2006-04-21 | 2009-08-13 | Cedars-Sinai Medical Center | Multiple imaging and/or spectroscopic modality probe |
WO2007146254A2 (en) | 2006-06-12 | 2007-12-21 | Prescient Medical, Inc. | Miniature fiber optic spectroscopy probes |
EP2083676A2 (en) * | 2006-10-20 | 2009-08-05 | InfraReDx, Inc. | Optical catheter and pullback and rotation system and method |
US20080097223A1 (en) | 2006-10-20 | 2008-04-24 | Infraredx, Inc. | Optical Catheter Carriage Interlock System and Method |
US7935060B2 (en) | 2006-11-08 | 2011-05-03 | Lightlab Imaging, Inc. | Opto-acoustic imaging devices and methods |
US9713448B2 (en) | 2008-04-03 | 2017-07-25 | Infraredx, Inc. | System and method for intravascular structural analysis compensation of chemical analysis modality |
-
2009
- 2009-05-07 US US12/437,022 patent/US8052605B2/en active Active
- 2009-05-07 JP JP2011508657A patent/JP2011519689A/en active Pending
- 2009-05-07 EP EP09743645A patent/EP2273916A1/en not_active Withdrawn
- 2009-05-07 WO PCT/US2009/043119 patent/WO2009137659A1/en active Application Filing
-
2011
- 2011-11-07 US US13/290,438 patent/US20120116214A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6501551B1 (en) * | 1991-04-29 | 2002-12-31 | Massachusetts Institute Of Technology | Fiber optic imaging endoscope interferometer with at least one faraday rotator |
US20050075574A1 (en) * | 2003-09-22 | 2005-04-07 | Simon Furnish | Devices for vulnerable plaque detection |
US20070135887A1 (en) * | 2005-12-12 | 2007-06-14 | Siemensaktiengesellschaft | Catheter device for treating a block-age of a vessel |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2777486A3 (en) * | 2013-03-15 | 2015-04-08 | Lightlab Imaging, Inc. | Apparatus and method of image registration |
US9833221B2 (en) | 2013-03-15 | 2017-12-05 | Lightlab Imaging, Inc. | Apparatus and method of image registration |
EP4052639A3 (en) * | 2013-03-15 | 2022-12-14 | Lightlab Imaging, Inc. | Apparatus and method of image registration |
KR101992333B1 (en) | 2016-12-22 | 2019-06-26 | 원텍 주식회사 | Fusion image acquiring system for cardiovascular disease diagnosis |
KR20180072949A (en) * | 2016-12-22 | 2018-07-02 | 원텍 주식회사 | Pullback device |
KR20180072948A (en) * | 2016-12-22 | 2018-07-02 | 원텍 주식회사 | Fusion image acquiring system for cardiovascular disease diagnosis |
KR101966217B1 (en) * | 2016-12-22 | 2019-04-08 | 원텍 주식회사 | Pullback device |
WO2018117392A1 (en) * | 2016-12-22 | 2018-06-28 | 원텍 주식회사 | Fusion image acquiring system for diagnosis of cardiovascular diseases |
WO2018117393A1 (en) * | 2016-12-22 | 2018-06-28 | 원텍 주식회사 | Pullback device |
WO2019055739A1 (en) | 2017-09-15 | 2019-03-21 | Infaredx, Inc. | Method of using an imaging catheter with a reinforced section |
EP3627993A4 (en) * | 2017-09-15 | 2021-06-16 | Infraredx, Inc. | Method of using an imaging catheter with a reinforced section |
US11284860B2 (en) | 2017-09-15 | 2022-03-29 | Infraredx, Inc. | Imaging catheter |
US11331074B2 (en) | 2017-09-15 | 2022-05-17 | Infraredx, Inc. | Method of using an imaging catheter with a reinforced section |
KR20190133741A (en) * | 2017-11-28 | 2019-12-03 | 오리오스메디칼 주식회사 | Optical coherence tomography system |
CN110691547A (en) * | 2017-11-28 | 2020-01-14 | 奥里斯医疗有限公司 | Optical coherence tomography system |
KR102293288B1 (en) * | 2017-11-28 | 2021-08-25 | 주식회사 도터 | Optical coherence tomography system |
Also Published As
Publication number | Publication date |
---|---|
EP2273916A1 (en) | 2011-01-19 |
US20090299195A1 (en) | 2009-12-03 |
WO2009137659A1 (en) | 2009-11-12 |
US8052605B2 (en) | 2011-11-08 |
JP2011519689A (en) | 2011-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8052605B2 (en) | Multimodal catheter system and method for intravascular analysis | |
US11317868B2 (en) | System and method for intravascular structural analysis compensation of chemical analysis modality | |
USRE49218E1 (en) | Systems and methods for improved visualization during minimally invasive procedures | |
US10058284B2 (en) | Simultaneous imaging, monitoring, and therapy | |
EP1667576B1 (en) | Devices for vulnerable plaque detection | |
US10219780B2 (en) | OCT-IVUS catheter for concurrent luminal imaging | |
US10076248B2 (en) | Hybrid catheter system | |
US20090281430A1 (en) | Catheter with spinning ultrasound transceiver board | |
JP6533078B2 (en) | Image diagnostic apparatus, control method thereof, program and computer readable storage medium | |
JP2016502883A (en) | Rotating imaging device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |